Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics

Revance Therapeutics, Inc. (RVNC): $7.15

0.10 (+1.42%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add RVNC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#67 of 347

in industry

RVNC Price/Volume Stats

Current price $7.15 52-week high $37.98
Prev. close $7.05 52-week low $5.72
Day low $7.15 Volume 1,272
Day high $7.15 Avg. volume 1,614,158
50-day MA $8.33 Dividend yield N/A
200-day MA $22.00 Market Cap 627.86M

RVNC Stock Price Chart Interactive Chart >

RVNC POWR Grades

  • RVNC scores best on the Growth dimension, with a Growth rank ahead of 91.46% of US stocks.
  • The strongest trend for RVNC is in Quality, which has been heading down over the past 177 days.
  • RVNC ranks lowest in Stability; there it ranks in the 2nd percentile.

RVNC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for RVNC is -2.02 -- better than just 4.62% of US stocks.
  • RVNC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 1.05% of US stocks.
  • Revenue growth over the past 12 months for REVANCE THERAPEUTICS INC comes in at 97.21%, a number that bests 95.09% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to REVANCE THERAPEUTICS INC are BHC, SOND, RENT, PTON, and MRAI.
  • Visit RVNC's SEC page to see the company's official filings. To visit the company's web site, go to www.revance.com.

RVNC Valuation Summary

  • In comparison to the median Healthcare stock, RVNC's EV/EBIT ratio is 118.9% lower, now standing at -2.4.
  • RVNC's price/sales ratio has moved down 731.4 over the prior 119 months.

Below are key valuation metrics over time for RVNC.

Stock Date P/S P/B P/E EV/EBIT
RVNC 2023-11-20 3.1 -6.2 -1.6 -2.4
RVNC 2023-11-17 3.0 -6.0 -1.5 -2.4
RVNC 2023-11-16 2.8 -5.7 -1.5 -2.3
RVNC 2023-11-15 2.9 -5.8 -1.5 -2.3
RVNC 2023-11-14 2.8 -5.6 -1.4 -2.3
RVNC 2023-11-13 2.4 -4.8 -1.2 -2.1

RVNC Growth Metrics

    Its 5 year cash and equivalents growth rate is now at 641.87%.
  • Its year over year revenue growth rate is now at 214.22%.
  • The year over year price growth rate now stands at -45.83%.
RVNC's revenue has moved up $108,181,000 over the prior 33 months.

The table below shows RVNC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 108.594 -207.977 -273.568
2022-06-30 99.324 -203.273 -263.251
2022-03-31 89.76 -208.053 -274.013
2021-12-31 77.798 -221.538 -281.31
2021-09-30 62.981 -239.241 -296.521
2021-06-30 47.071 -241.76 -303.402

RVNC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RVNC has a Quality Grade of D, ranking ahead of 5.83% of graded US stocks.
  • RVNC's asset turnover comes in at 0.068 -- ranking 297th of 681 Pharmaceutical Products stocks.
  • HGEN, ZSAN, and ARMP are the stocks whose asset turnover ratios are most correlated with RVNC.

The table below shows RVNC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.068 0.694 -0.733
2021-03-31 0.043 0.685 -0.794
2020-12-31 0.024 0.689 -0.784
2020-09-30 0.008 0.742 -0.784
2020-06-30 0.001 0.957 -0.721
2020-03-31 0.001 1.000 -0.749

RVNC Price Target

For more insight on analysts targets of RVNC, see our RVNC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $39.78 Average Broker Recommendation 1.35 (Strong Buy)

Revance Therapeutics, Inc. (RVNC) Company Bio


Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company was founded in 1999 and is based in Newark, California.


RVNC Latest News Stream


Event/Time News Detail
Loading, please wait...

RVNC Latest Social Stream


Loading social stream, please wait...

View Full RVNC Social Stream

Latest RVNC News From Around the Web

Below are the latest news stories about REVANCE THERAPEUTICS INC that investors may wish to consider to help them evaluate RVNC as an investment opportunity.

Analysts Just Slashed Their Revance Therapeutics, Inc. (NASDAQ:RVNC) EPS Numbers

One thing we could say about the analysts on Revance Therapeutics, Inc. ( NASDAQ:RVNC ) - they aren't optimistic...

Yahoo | November 10, 2023

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript November 8, 2023 Revance Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.63 EPS, expectations were $-1.1. Operator: Welcome to the Revance Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following management’s […]

Yahoo | November 10, 2023

Q3 2023 Revance Therapeutics Inc Earnings Call

Q3 2023 Revance Therapeutics Inc Earnings Call

Yahoo | November 9, 2023

Revance Therapeutics, Inc. (RVNC) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Revance Therapeutics, Inc. (RVNC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Yahoo | November 9, 2023

Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

NASHVILLE, November 08, 2023--Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

Yahoo | November 8, 2023

Read More 'RVNC' Stories Here

RVNC Price Returns

1-mo -16.76%
3-mo -53.84%
6-mo -76.06%
1-year -66.54%
3-year -70.20%
5-year -69.06%
YTD -61.27%
2022 13.11%
2021 -42.41%
2020 74.61%
2019 -19.37%
2018 -43.69%

Continue Researching RVNC

Here are a few links from around the web to help you further your research on Revance Therapeutics Inc's stock as an investment opportunity:

Revance Therapeutics Inc (RVNC) Stock Price | Nasdaq
Revance Therapeutics Inc (RVNC) Stock Quote, History and News - Yahoo Finance
Revance Therapeutics Inc (RVNC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!